Monashee Investment Management LLC Fulcrum Therapeutics, Inc. Transaction History

Monashee Investment Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 01, 2022	BUY	$4.92 - $9.1 $984,000 - $1.82 Million	200,000 New	200,000 $1.62 Million
Q2 2022 Aug 12, 2022	SELL	$4.2 - $24.0 $995,362 - $5.69 Million	-236,991 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$9.96 - $23.65 $359,097 - $852,677	-36,054 Reduced 13.2%	236,991 $5.6 Million
Q4 2021 Feb 07, 2022	BUY	$14.0 - $28.44 $3.82 Million - $7.77 Million	273,045 New	273,045 $4.83 Million
Q3 2020 Nov 13, 2020	SELL	$7.22 - $20.7 $2.12 Million - $6.09 Million	-294,118 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$9.11 - $22.06 $2.68 Million - $6.49 Million	294,118 New	294,118 $5.38 Million

150

52.2M

6.91M

1.9M

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $169M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Monashee Investment Management LLC with notifications on news.